Rodman & Renshaw Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Rodman & Renshaw
Rating: 2.7
Author: MarketBeat

→ Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad)

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Rodman & Renshaw. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Rodman & Renshaw.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
BHC Bausch Health Companies	$8.63 +0.7%	8/10/2017	Reiterated by	Rodman & Renshaw	-	Neutral	$17.00	High	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 8/10/2017
CRMD CorMedix	$5.19 -2.6%	8/10/2017	Target Lowered by	Rodman & Renshaw	-	Buy -> Buy	$25.00 -> $15.00	N/A	View details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 8/10/2017
GEVO Gevo	$0.60 -10.5%	8/9/2017	Reiterated by	Rodman & Renshaw	-	Buy	$240.00	Medium	View details for Rodman & Renshaw rating of Gevo (NASDAQ:GEVO) on 8/9/2017
POETF POET Technologies	$2.28 +44.3%	8/7/2017	Initiated by	Rodman & Renshaw	-	Buy		High	View details for Rodman & Renshaw rating of POET Technologies (OTCMKTS:POETF) on 8/7/2017
VERU Veru	$1.21 -8.3%	7/26/2017	Initiated by	Rodman & Renshaw	-	Buy -> Buy	$5.00	High	View details for Rodman & Renshaw rating of Veru (NASDAQ:VERU) on 7/26/2017
PLUG Plug Power	$2.38 -1.2%	7/24/2017	Reiterated by	Rodman & Renshaw	-	Buy	$4.00	Low	View details for Rodman & Renshaw rating of Plug Power (NASDAQ:PLUG) on 7/24/2017
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
CAPR Capricor Therapeutics	$5.15 +2.2%	7/22/2017	Reiterated by	Rodman & Renshaw	-	Buy	$2.15	N/A	View details for Rodman & Renshaw rating of Capricor Therapeutics (NASDAQ:CAPR) on 7/22/2017
BYSI BeyondSpring	$2.27 -6.6%	7/14/2017	Target Raised by	Rodman & Renshaw	-	Buy -> Buy	$43.00 -> $50.00	Medium	View details for Rodman & Renshaw rating of BeyondSpring (NASDAQ:BYSI) on 7/14/2017
JAGX Jaguar Health	$0.17	7/11/2017	Initiated by	Rodman & Renshaw	-	Buy -> Buy	$6.00	High	View details for Rodman & Renshaw rating of Jaguar Health (NASDAQ:JAGX) on 7/11/2017
FBIO Fortress Biotech	$1.72 -3.9%	7/11/2017	Initiated by	Rodman & Renshaw	-	Buy -> Buy	$165.00	Low	View details for Rodman & Renshaw rating of Fortress Biotech (NASDAQ:FBIO) on 7/11/2017
AQMS Aqua Metals	$0.51 +6.3%	7/2/2017	Initiated by	Rodman & Renshaw	-	Buy	$25.00 -> $25.00	Low	View details for Rodman & Renshaw rating of Aqua Metals (NASDAQ:AQMS) on 7/2/2017
EMAN eMagin	$2.07	6/23/2017	Reiterated by	Rodman & Renshaw	-	Buy	$4.00	N/A	View details for Rodman & Renshaw rating of eMagin (NYSEAMERICAN:EMAN) on 6/23/2017
AQMS Aqua Metals	$0.51 +6.3%	6/22/2017	Initiated by	Rodman & Renshaw	-	Buy -> Buy	$25.00	Low	View details for Rodman & Renshaw rating of Aqua Metals (NASDAQ:AQMS) on 6/22/2017
USA Americas Silver	C$0.37 +5.8%	6/15/2017	Initiated by	Rodman & Renshaw	-	Buy	C$4.00	N/A	View details for Rodman & Renshaw rating of Americas Silver (TSE:USA) on 6/15/2017
USAS Americas Silver	$0.26 +1.4%	6/15/2017	Initiated by	Rodman & Renshaw	-	Buy -> Buy	$4.00 -> $4.00	Medium	View details for Rodman & Renshaw rating of Americas Silver (NYSEAMERICAN:USAS) on 6/15/2017
APTO Aptose Biosciences	$1.16 -4.9%	6/8/2017	Initiated by	Rodman & Renshaw	-	Neutral -> Neutral		High	View details for Rodman & Renshaw rating of Aptose Biosciences (NASDAQ:APTO) on 6/8/2017
EYPT EyePoint Pharmaceuticals	$16.16 -1.9%	5/30/2017	Initiated by	Rodman & Renshaw	-	Buy	$800.00	High	View details for Rodman & Renshaw rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 5/30/2017
PIRS Pieris Pharmaceuticals	$11.60 -2.8%	5/30/2017	Initiated by	Rodman & Renshaw	-	Buy -> Buy	$720.00	High	View details for Rodman & Renshaw rating of Pieris Pharmaceuticals (NASDAQ:PIRS) on 5/30/2017
PLX Protalix BioTherapeutics	$1.18 -2.5%	5/23/2017	Reiterated by	Rodman & Renshaw	-	Buy	$50.00	N/A	View details for Rodman & Renshaw rating of Protalix BioTherapeutics (NYSE:PLX) on 5/23/2017
ACAD ACADIA Pharmaceuticals	$16.31 -1.7%	5/22/2017	Reiterated by	Rodman & Renshaw	-	Buy	$60.00	Low	View details for Rodman & Renshaw rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 5/22/2017
SRNE Sorrento Therapeutics	$0.02	5/22/2017	Target Lowered by	Rodman & Renshaw	-	Buy -> Buy	$30.00 -> $20.00	High	View details for Rodman & Renshaw rating of Sorrento Therapeutics (NASDAQ:SRNE) on 5/22/2017
BHC Bausch Health Companies	$8.63 +0.7%	5/19/2017	Reiterated by	Rodman & Renshaw	-	Neutral	$17.00	Medium	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 5/19/2017
MGIC Magic Software Enterprises	$11.58 -0.3%	5/17/2017	Reiterated by	Rodman & Renshaw	-	Buy -> Buy	$9.00 -> $10.00	Medium	View details for Rodman & Renshaw rating of Magic Software Enterprises (NASDAQ:MGIC) on 5/17/2017
SSKN STRATA Skin Sciences	$0.53 -5.4%	5/16/2017	Target Raised by	Rodman & Renshaw	-	Buy -> Buy	$1.50 -> $12.00	High	View details for Rodman & Renshaw rating of STRATA Skin Sciences (NASDAQ:SSKN) on 5/16/2017
IOVA Iovance Biotherapeutics	$11.54 -1.5%	5/10/2017	Initiated by	Rodman & Renshaw	-	Buy -> Buy	$13.00	Low	View details for Rodman & Renshaw rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 5/10/2017
CRMD CorMedix	$5.19 -2.6%	5/5/2017	Target Lowered by	Rodman & Renshaw	-	Buy	$30.00 -> $25.00	N/A	View details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 5/5/2017
AMSC American Superconductor	$11.86 -0.1%	4/28/2017	Reiterated by	Rodman & Renshaw	-	Buy -> Buy	$10.00 -> $7.50	High	View details for Rodman & Renshaw rating of American Superconductor (NASDAQ:AMSC) on 4/28/2017
ALIM Alimera Sciences	$3.31 -8.8%	4/27/2017	Initiated by	Rodman & Renshaw	-	Buy -> Buy	$60.00	High	View details for Rodman & Renshaw rating of Alimera Sciences (NASDAQ:ALIM) on 4/27/2017
GOLD Barrick Gold	$17.07 +3.3%	4/24/2017	Target Raised by	Rodman & Renshaw	-	Buy	$4.25 -> $4.50	N/A	View details for Rodman & Renshaw rating of Barrick Gold (NYSE:GOLD) on 4/24/2017
PLX Protalix BioTherapeutics	$1.18 -2.5%	4/17/2017	Target Raised by	Rodman & Renshaw	-	Buy	$40.00 -> $50.00	N/A	View details for Rodman & Renshaw rating of Protalix BioTherapeutics (NYSE:PLX) on 4/17/2017
PLX Protalix BioTherapeutics	$1.18 -2.5%	4/17/2017	Reiterated by	Rodman & Renshaw	-	Buy -> Buy	$40.00 -> $50.00	N/A	View details for Rodman & Renshaw rating of Protalix BioTherapeutics (NYSE:PLX) on 4/17/2017
WRN Western Copper and Gold	C$1.98 +1.5%	4/10/2017	Reiterated by	Rodman & Renshaw	-	Buy	C$2.00	N/A	View details for Rodman & Renshaw rating of Western Copper and Gold (TSE:WRN) on 4/10/2017
WRN Western Copper and Gold	$1.45 +1.4%	4/7/2017	Reiterated by	Rodman & Renshaw	-	Buy	$2.00	Medium	View details for Rodman & Renshaw rating of Western Copper and Gold (NYSEAMERICAN:WRN) on 4/7/2017
PLUG Plug Power	$2.38 -1.2%	4/6/2017	Target Raised by	Rodman & Renshaw	-	Buy -> Buy	$3.00 -> $4.00	High	View details for Rodman & Renshaw rating of Plug Power (NASDAQ:PLUG) on 4/6/2017
BYSI BeyondSpring	$2.27 -6.6%	4/4/2017	Initiated by	Rodman & Renshaw	-	Buy -> Buy	$43.00	Low	View details for Rodman & Renshaw rating of BeyondSpring (NASDAQ:BYSI) on 4/4/2017
CYTK Cytokinetics	$64.80 -3.0%	3/23/2017	Reiterated by	Rodman & Renshaw	-	Buy	$25.00	Medium	View details for Rodman & Renshaw rating of Cytokinetics (NASDAQ:CYTK) on 3/23/2017
HROW Harrow Health	$10.00 -2.6%	3/22/2017	Reiterated by	Rodman & Renshaw	-	Buy	$5.00	High	View details for Rodman & Renshaw rating of Harrow Health (NASDAQ:HROW) on 3/22/2017
MAG MAG Silver	$12.97 +7.5%	3/9/2017	Reiterated by	Rodman & Renshaw	-	Buy -> Buy	$20.00 -> $20.50	Low	View details for Rodman & Renshaw rating of MAG Silver (NYSEAMERICAN:MAG) on 3/9/2017
CYTK Cytokinetics	$64.80 -3.0%	3/8/2017	Initiated by	Rodman & Renshaw	-	Buy -> Buy	$25.00	High	View details for Rodman & Renshaw rating of Cytokinetics (NASDAQ:CYTK) on 3/8/2017
BHC Bausch Health Companies	$8.63 +0.7%	3/6/2017	Target Lowered by	Rodman & Renshaw	-	Neutral	$23.00 -> $17.00	N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 3/6/2017
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>>
MGIC Magic Software Enterprises	$11.58 -0.3%	3/6/2017	Reiterated by	Rodman & Renshaw	-	Buy -> Buy	$8.00 -> $9.00	N/A	View details for Rodman & Renshaw rating of Magic Software Enterprises (NASDAQ:MGIC) on 3/6/2017
QRHC Quest Resource	$9.34 -0.4%	3/6/2017	Initiated by	Rodman & Renshaw	-	Buy -> Buy	$5.00	N/A	View details for Rodman & Renshaw rating of Quest Resource (NASDAQ:QRHC) on 3/6/2017
BHC Bausch Health Companies	$8.63 +0.7%	2/27/2017	Reiterated by	Rodman & Renshaw	-	Neutral	$23.00 -> $17.00	N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 2/27/2017
SSKN STRATA Skin Sciences	$0.53 -5.4%	2/21/2017	Reiterated by	Rodman & Renshaw	-	Buy -> Buy	$1.50	N/A	View details for Rodman & Renshaw rating of STRATA Skin Sciences (NASDAQ:SSKN) on 2/21/2017
CAPR Capricor Therapeutics	$5.15 +2.2%	2/13/2017	Initiated by	Rodman & Renshaw	-	Buy	$14.00	N/A	View details for Rodman & Renshaw rating of Capricor Therapeutics (NASDAQ:CAPR) on 2/13/2017
BLRX BioLineRx	$0.58 -6.5%	2/13/2017	Initiated by	Rodman & Renshaw	-	Buy	$3.00	N/A	View details for Rodman & Renshaw rating of BioLineRx (NASDAQ:BLRX) on 2/13/2017
ABEO Abeona Therapeutics	$3.19 +0.6%	2/7/2017	Reiterated by	Rodman & Renshaw	Analyst ram selvaraju	Buy	$425.00 -> $500.00	N/A	View details for Rodman & Renshaw rating of Abeona Therapeutics (NASDAQ:ABEO) on 2/7/2017
BHC Bausch Health Companies	$8.63 +0.7%	1/31/2017	Downgraded by	Rodman & Renshaw	-	Buy -> Neutral		N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 1/31/2017
ASM Avino Silver & Gold Mines	$0.75 +5.6%	1/24/2017	Target Raised by	Rodman & Renshaw	-	Buy	$3.50 -> $4.00	N/A	View details for Rodman & Renshaw rating of Avino Silver & Gold Mines (NYSE:ASM) on 1/24/2017
ASM Avino Silver & Gold Mines	$0.75 +5.6%	1/24/2017	Target Raised by	Rodman & Renshaw	-	Buy	$3.50 -> $4.00	N/A	View details for Rodman & Renshaw rating of Avino Silver & Gold Mines (NYSE:ASM) on 1/24/2017
CHEK Check-Cap	$2.30 +3.6%	1/19/2017	Initiated by	Rodman & Renshaw	-	Buy	$1,440.00	N/A	View details for Rodman & Renshaw rating of Check-Cap (NASDAQ:CHEK) on 1/19/2017
CDXC ChromaDex	$3.39 -0.3%	1/3/2017	Initiated by	Rodman & Renshaw	-	Buy	$6.00	N/A	View details for Rodman & Renshaw rating of ChromaDex (NASDAQ:CDXC) on 1/3/2017
PLUG Plug Power	$2.38 -1.2%	12/6/2016	Initiated by	Rodman & Renshaw	-	Buy	$3.00	N/A	View details for Rodman & Renshaw rating of Plug Power (NASDAQ:PLUG) on 12/6/2016
GOLD Barrick Gold	$17.07 +3.3%	11/28/2016	Target Raised by	Rodman & Renshaw	-	Buy	$4.00 -> $4.25	N/A	View details for Rodman & Renshaw rating of Barrick Gold (NYSE:GOLD) on 11/28/2016
HROW Harrow Health	$10.00 -2.6%	11/28/2016	Initiated by	Rodman & Renshaw	-	Buy	$5.00	N/A	View details for Rodman & Renshaw rating of Harrow Health (NASDAQ:HROW) on 11/28/2016
BHC Bausch Health Companies	$8.63 +0.7%	11/10/2016	Downgraded by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy -> Neutral	$81.00 -> $23.00	N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 11/10/2016
GGD GoGold Resources	C$1.37 +4.6%	10/7/2016	Target Lowered by	Rodman & Renshaw	-	Buy	C$3.50 -> C$3.00	N/A	View details for Rodman & Renshaw rating of GoGold Resources (TSE:GGD) on 10/7/2016
CYDY CytoDyn	$0.15	10/6/2016	Initiated by	Rodman & Renshaw	-	Buy	$1.60	N/A	View details for Rodman & Renshaw rating of CytoDyn (OTCMKTS:CYDY) on 10/6/2016
DRRX DURECT	$0.92 +3.4%	9/27/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$40.00 -> $35.00	N/A	View details for Rodman & Renshaw rating of DURECT (NASDAQ:DRRX) on 9/27/2016
AYTU Aytu BioPharma	$2.84 +1.4%	9/26/2016	Initiated by	Rodman & Renshaw	-	Buy	$9.00	N/A	View details for Rodman & Renshaw rating of Aytu BioPharma (NASDAQ:AYTU) on 9/26/2016
CLNE Clean Energy Fuels	$2.25 -1.7%	9/23/2016	Reiterated by	Rodman & Renshaw	-	Buy	$5.00 -> $6.30	N/A	View details for Rodman & Renshaw rating of Clean Energy Fuels (NASDAQ:CLNE) on 9/23/2016
UUUU Energy Fuels	$5.37 +0.2%	9/22/2016	Target Raised by	Rodman & Renshaw	-	Buy	$5.00 -> $6.30	N/A	View details for Rodman & Renshaw rating of Energy Fuels (NYSE:UUUU) on 9/22/2016
UUUU Energy Fuels	$5.37 +0.2%	9/22/2016	Target Lowered by	Rodman & Renshaw	-	Buy	$6.30 -> $5.00	N/A	View details for Rodman & Renshaw rating of Energy Fuels (NYSE:UUUU) on 9/22/2016
VNRX VolitionRx	$0.89 +11.2%	9/7/2016	Target Lowered by	Rodman & Renshaw	-	Buy	$12.00 -> $10.00	N/A	View details for Rodman & Renshaw rating of VolitionRx (NYSEAMERICAN:VNRX) on 9/7/2016
VNRX VolitionRx	$0.89 +11.2%	9/7/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$12.00 -> $10.00	N/A	View details for Rodman & Renshaw rating of VolitionRx (NYSEAMERICAN:VNRX) on 9/7/2016
MEEC Midwest Energy Emissions	$0.78 +1.2%	9/7/2016	Initiated by	Rodman & Renshaw	-	Buy	$2.50	N/A	View details for Rodman & Renshaw rating of Midwest Energy Emissions (OTCMKTS:MEEC) on 9/7/2016
HL Hecla Mining	$5.05 -3.8%	9/6/2016	Initiated by	Rodman & Renshaw	-	Buy	$9.00	N/A	View details for Rodman & Renshaw rating of Hecla Mining (NYSE:HL) on 9/6/2016
REI Ring Energy	$1.99 +1.5%	8/29/2016	Initiated by	Rodman & Renshaw	-	Buy	$15.00	N/A	View details for Rodman & Renshaw rating of Ring Energy (NYSEAMERICAN:REI) on 8/29/2016
DRIO DarioHealth	$1.47 -2.0%	8/22/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$12.00	N/A	View details for Rodman & Renshaw rating of DarioHealth (NASDAQ:DRIO) on 8/22/2016
ORMP Oramed Pharmaceuticals	$2.30 -3.0%	8/21/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$25.00	N/A	View details for Rodman & Renshaw rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 8/21/2016
ABEO Abeona Therapeutics	$3.19 +0.6%	8/21/2016	Reiterated by	Rodman & Renshaw	-	Buy	$425.00	N/A	View details for Rodman & Renshaw rating of Abeona Therapeutics (NASDAQ:ABEO) on 8/21/2016
SMT Sierra Metals	C$0.80	8/18/2016	Reiterated by	Rodman & Renshaw	-	Buy	C$3.00	N/A	View details for Rodman & Renshaw rating of Sierra Metals (TSE:SMT) on 8/18/2016
BHC Bausch Health Companies	$8.63 +0.7%	8/9/2016	Target Lowered by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$90.00 -> $81.00	N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 8/9/2016
ABEO Abeona Therapeutics	$3.19 +0.6%	8/5/2016	Reiterated by	Rodman & Renshaw	-	Buy	$425.00	N/A	View details for Rodman & Renshaw rating of Abeona Therapeutics (NASDAQ:ABEO) on 8/5/2016
DRRX DURECT	$0.92 +3.4%	8/3/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$40.00	N/A	View details for Rodman & Renshaw rating of DURECT (NASDAQ:DRRX) on 8/3/2016
EKSO Ekso Bionics	$1.28 +8.5%	7/31/2016	Reiterated by	Rodman & Renshaw	-	Buy		N/A	View details for Rodman & Renshaw rating of Ekso Bionics (NASDAQ:EKSO) on 7/31/2016
BHC Bausch Health Companies	$8.63 +0.7%	7/28/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$90.00	N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 7/28/2016
F Ford Motor	$13.04 +0.7%	7/18/2016	Initiated by	Rodman & Renshaw	-	Buy		N/A	View details for Rodman & Renshaw rating of Ford Motor (NYSE:F) on 7/18/2016
OESX Orion Energy Systems	$0.85 -3.4%	7/18/2016	Initiated by	Rodman & Renshaw	-	Buy	$2.50	N/A	View details for Rodman & Renshaw rating of Orion Energy Systems (NASDAQ:OESX) on 7/18/2016
SRNE Sorrento Therapeutics	$0.02	7/17/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A	View details for Rodman & Renshaw rating of Sorrento Therapeutics (NASDAQ:SRNE) on 7/17/2016
BHC Bausch Health Companies	$8.63 +0.7%	7/17/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$90.00	N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 7/17/2016
SRNE Sorrento Therapeutics	$0.02	7/11/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A	View details for Rodman & Renshaw rating of Sorrento Therapeutics (NASDAQ:SRNE) on 7/11/2016
PLX Protalix BioTherapeutics	$1.18 -2.5%	7/11/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A	View details for Rodman & Renshaw rating of Protalix BioTherapeutics (NYSE:PLX) on 7/11/2016
BHC Bausch Health Companies	$8.63 +0.7%	7/6/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$90.00	N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 7/6/2016
DRRX DURECT	$0.92 +3.4%	7/6/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$40.00	N/A	View details for Rodman & Renshaw rating of DURECT (NASDAQ:DRRX) on 7/6/2016
INO Inovio Pharmaceuticals	$10.13 -0.4%	6/21/2016	Reiterated by	Rodman & Renshaw	-	Buy	$2,448.00	N/A	View details for Rodman & Renshaw rating of Inovio Pharmaceuticals (NASDAQ:INO) on 6/21/2016
WPRT Westport Fuel Systems	$5.66 +0.7%	6/20/2016	Initiated by	Rodman & Renshaw	-	Buy	$50.00	N/A	View details for Rodman & Renshaw rating of Westport Fuel Systems (NASDAQ:WPRT) on 6/20/2016
VNRX VolitionRx	$0.89 +11.2%	6/16/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A	View details for Rodman & Renshaw rating of VolitionRx (NYSEAMERICAN:VNRX) on 6/16/2016
SRNE Sorrento Therapeutics	$0.02	6/8/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A	View details for Rodman & Renshaw rating of Sorrento Therapeutics (NASDAQ:SRNE) on 6/8/2016
DRIO DarioHealth	$1.47 -2.0%	5/24/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$12.00	N/A	View details for Rodman & Renshaw rating of DarioHealth (NASDAQ:DRIO) on 5/24/2016
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>>
ABEO Abeona Therapeutics	$3.19 +0.6%	5/18/2016	Reiterated by	Rodman & Renshaw	-	Buy	$425.00	N/A	View details for Rodman & Renshaw rating of Abeona Therapeutics (NASDAQ:ABEO) on 5/18/2016
VNRX VolitionRx	$0.89 +11.2%	5/16/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A	View details for Rodman & Renshaw rating of VolitionRx (NYSEAMERICAN:VNRX) on 5/16/2016
DRRX DURECT	$0.92 +3.4%	5/13/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$40.00	N/A	View details for Rodman & Renshaw rating of DURECT (NASDAQ:DRRX) on 5/13/2016
ORMP Oramed Pharmaceuticals	$2.30 -3.0%	5/13/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$25.00	N/A	View details for Rodman & Renshaw rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 5/13/2016
MBOT Microbot Medical	$0.86 -3.4%	5/10/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A	View details for Rodman & Renshaw rating of Microbot Medical (NASDAQ:MBOT) on 5/10/2016
DRIO DarioHealth	$1.47 -2.0%	5/9/2016	Initiated by	Rodman & Renshaw	-	Buy	$12.00	N/A	View details for Rodman & Renshaw rating of DarioHealth (NASDAQ:DRIO) on 5/9/2016
BHC Bausch Health Companies	$8.63 +0.7%	5/3/2016	Target Lowered by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$105.00 -> $102.00	N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 5/3/2016
BHC Bausch Health Companies	$8.63 +0.7%	4/26/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$105.00	N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 4/26/2016
DRRX DURECT	$0.92 +3.4%	4/25/2016	Initiated by	Rodman & Renshaw	-	Buy	$40.00	N/A	View details for Rodman & Renshaw rating of DURECT (NASDAQ:DRRX) on 4/25/2016
VNRX VolitionRx	$0.89 +11.2%	4/21/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A	View details for Rodman & Renshaw rating of VolitionRx (NYSEAMERICAN:VNRX) on 4/21/2016
ABEO Abeona Therapeutics	$3.19 +0.6%	4/20/2016	Reiterated by	Rodman & Renshaw	-	Buy	$425.00	N/A	View details for Rodman & Renshaw rating of Abeona Therapeutics (NASDAQ:ABEO) on 4/20/2016
MBOT Microbot Medical	$0.86 -3.4%	4/20/2016	Initiated by	Rodman & Renshaw	-	Buy	$18.00	N/A	View details for Rodman & Renshaw rating of Microbot Medical (NASDAQ:MBOT) on 4/20/2016
AG First Majestic Silver	$6.94 +2.1%	4/15/2016	Target Raised by	Rodman & Renshaw	-	Buy	$6.00 -> $8.75	N/A	View details for Rodman & Renshaw rating of First Majestic Silver (NYSE:AG) on 4/15/2016
SMLR Semler Scientific	$25.91 -2.7%	4/15/2016	Initiated by	Rodman & Renshaw	-	Buy	$8.00	N/A	View details for Rodman & Renshaw rating of Semler Scientific (NASDAQ:SMLR) on 4/15/2016
EXK Endeavour Silver	$2.79 +3.0%	4/12/2016	Target Raised by	Rodman & Renshaw	-	Buy	$2.50 -> $3.40	N/A	View details for Rodman & Renshaw rating of Endeavour Silver (NYSE:EXK) on 4/12/2016
BHC Bausch Health Companies	$8.63 +0.7%	4/11/2016	Target Lowered by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$118.00 -> $105.00	N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 4/11/2016
INO Inovio Pharmaceuticals	$10.13 -0.4%	4/9/2016	Reiterated by	Rodman & Renshaw	-	Buy		N/A	View details for Rodman & Renshaw rating of Inovio Pharmaceuticals (NASDAQ:INO) on 4/9/2016
VNRX VolitionRx	$0.89 +11.2%	4/9/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A	View details for Rodman & Renshaw rating of VolitionRx (NYSEAMERICAN:VNRX) on 4/9/2016
SRNE Sorrento Therapeutics	$0.02	4/5/2016	Target Lowered by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$40.00 -> $30.00	N/A	View details for Rodman & Renshaw rating of Sorrento Therapeutics (NASDAQ:SRNE) on 4/5/2016
EKSO Ekso Bionics	$1.28 +8.5%	4/5/2016	Reiterated by	Rodman & Renshaw	-	Buy	$21.00	N/A	View details for Rodman & Renshaw rating of Ekso Bionics (NASDAQ:EKSO) on 4/5/2016
PLX Protalix BioTherapeutics	$1.18 -2.5%	4/4/2016	Initiated by	Rodman & Renshaw	-	Buy	$35.00	N/A	View details for Rodman & Renshaw rating of Protalix BioTherapeutics (NYSE:PLX) on 4/4/2016
BHC Bausch Health Companies	$8.63 +0.7%	4/3/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 4/3/2016
AMSC American Superconductor	$11.86 -0.1%	4/1/2016	Reiterated by	Rodman & Renshaw	Analyst Amit Dayal	Neutral		N/A	View details for Rodman & Renshaw rating of American Superconductor (NASDAQ:AMSC) on 4/1/2016
BHC Bausch Health Companies	$8.63 +0.7%	3/28/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$118.00	N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 3/28/2016
BHC Bausch Health Companies	$8.63 +0.7%	3/22/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 3/22/2016
SRNE Sorrento Therapeutics	$0.02	3/21/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$40.00	N/A	View details for Rodman & Renshaw rating of Sorrento Therapeutics (NASDAQ:SRNE) on 3/21/2016
NNDM Nano Dimension	$2.46 -2.0%	3/21/2016	Initiated by	Rodman & Renshaw	-	Buy	$700.00	N/A	View details for Rodman & Renshaw rating of Nano Dimension (NASDAQ:NNDM) on 3/21/2016
INO Inovio Pharmaceuticals	$10.13 -0.4%	3/20/2016	Reiterated by	Rodman & Renshaw	-	Buy		N/A	View details for Rodman & Renshaw rating of Inovio Pharmaceuticals (NASDAQ:INO) on 3/20/2016
UUUU Energy Fuels	$5.37 +0.2%	3/17/2016	Target Lowered by	Rodman & Renshaw	-	Buy	$6.90 -> $6.30	N/A	View details for Rodman & Renshaw rating of Energy Fuels (NYSE:UUUU) on 3/17/2016
CRMD CorMedix	$5.19 -2.6%	3/17/2016	Target Raised by	Rodman & Renshaw	-	Buy	$32.50 -> $37.50	N/A	View details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 3/17/2016
BHC Bausch Health Companies	$8.63 +0.7%	3/16/2016	Target Lowered by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$150.00 -> $118.00	N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 3/16/2016
MUX McEwen Mining	$11.94 +9.3%	3/14/2016	Target Raised by	Rodman & Renshaw	-		$13.00 -> $24.00	N/A	View details for Rodman & Renshaw rating of McEwen Mining (NYSE:MUX) on 3/14/2016
VNRX VolitionRx	$0.89 +11.2%	3/14/2016	Reiterated by	Rodman & Renshaw	-	Buy	$12.00	N/A	View details for Rodman & Renshaw rating of VolitionRx (NYSEAMERICAN:VNRX) on 3/14/2016
INSG Inseego	$3.53 +9.3%	3/7/2016	Target Lowered by	Rodman & Renshaw	-	Buy	$60.00 -> $30.00	N/A	View details for Rodman & Renshaw rating of Inseego (NASDAQ:INSG) on 3/7/2016
SRNE Sorrento Therapeutics	$0.02	3/7/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$40.00	N/A	View details for Rodman & Renshaw rating of Sorrento Therapeutics (NASDAQ:SRNE) on 3/7/2016
PLM PolyMet Mining	$2.10 -0.5%	3/4/2016	Target Raised by	Rodman & Renshaw	-	Buy	$2.00 -> $2.40	N/A	View details for Rodman & Renshaw rating of PolyMet Mining (NYSEAMERICAN:PLM) on 3/4/2016
BHC Bausch Health Companies	$8.63 +0.7%	3/2/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 3/2/2016
SRNE Sorrento Therapeutics	$0.02	2/29/2016	Target Lowered by	Rodman & Renshaw	-	Buy	$45.00 -> $40.00	N/A	View details for Rodman & Renshaw rating of Sorrento Therapeutics (NASDAQ:SRNE) on 2/29/2016
AG First Majestic Silver	$6.94 +2.1%	2/29/2016	Initiated by	Rodman & Renshaw	-	Buy	$6.00	N/A	View details for Rodman & Renshaw rating of First Majestic Silver (NYSE:AG) on 2/29/2016
EXK Endeavour Silver	$2.79 +3.0%	2/29/2016	Initiated by	Rodman & Renshaw	-	Buy	$2.50	N/A	View details for Rodman & Renshaw rating of Endeavour Silver (NYSE:EXK) on 2/29/2016
BHC Bausch Health Companies	$8.63 +0.7%	2/23/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$150.00	N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 2/23/2016
RDCM RADCOM	$8.74 -0.7%	2/18/2016	Target Raised by	Rodman & Renshaw	-	Buy	$12.00 -> $16.00	N/A	View details for Rodman & Renshaw rating of RADCOM (NASDAQ:RDCM) on 2/18/2016
BHC Bausch Health Companies	$8.63 +0.7%	2/16/2016	Initiated by	Rodman & Renshaw	-	Buy	$150.00	N/A	View details for Rodman & Renshaw rating of Bausch Health Companies (NYSE:BHC) on 2/16/2016
TMQ Trilogy Metals	$0.42 +4.9%	2/11/2016	Reiterated by	Rodman & Renshaw	-	Buy	$1.40 -> $1.30	N/A	View details for Rodman & Renshaw rating of Trilogy Metals (NYSEAMERICAN:TMQ) on 2/11/2016
TMQ Trilogy Metals	$0.42 +4.9%	2/10/2016	Target Lowered by	Rodman & Renshaw	-	Buy	$1.40 -> $1.30	N/A	View details for Rodman & Renshaw rating of Trilogy Metals (NYSEAMERICAN:TMQ) on 2/10/2016
BCRX BioCryst Pharmaceuticals	$4.16 -1.2%	2/9/2016	Target Lowered by	Rodman & Renshaw	-	Buy	$24.00 -> $10.00	N/A	View details for Rodman & Renshaw rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 2/9/2016
VNRX VolitionRx	$0.89 +11.2%	2/1/2016	Initiated by	Rodman & Renshaw	-	Buy	$12.00	N/A	View details for Rodman & Renshaw rating of VolitionRx (NYSEAMERICAN:VNRX) on 2/1/2016
INO Inovio Pharmaceuticals	$10.13 -0.4%	1/29/2016	Reiterated by	Rodman & Renshaw	-	Buy		N/A	View details for Rodman & Renshaw rating of Inovio Pharmaceuticals (NASDAQ:INO) on 1/29/2016
IPWR Ideal Power	$7.50 +0.4%	1/26/2016	Initiated by	Rodman & Renshaw	-	Buy	$12.00	N/A	View details for Rodman & Renshaw rating of Ideal Power (NASDAQ:IPWR) on 1/26/2016
AMSC American Superconductor	$11.86 -0.1%	1/13/2016	Initiated by	Rodman & Renshaw	-	Buy	$10.00	N/A	View details for Rodman & Renshaw rating of American Superconductor (NASDAQ:AMSC) on 1/13/2016
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>>
NB NioCorp Developments	C$3.24 -4.7%	1/12/2016	Target Lowered by	Rodman & Renshaw	-	Buy	C$1.40 -> C$1.20	N/A	View details for Rodman & Renshaw rating of NioCorp Developments (TSE:NB) on 1/12/2016
ORMP Oramed Pharmaceuticals	$2.30 -3.0%	1/10/2016	Reiterated by	Rodman & Renshaw	-	Buy	$25.00	N/A	View details for Rodman & Renshaw rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 1/10/2016
GGD GoGold Resources	C$1.37 +4.6%	12/21/2015	Target Raised by	Rodman & Renshaw	-		C$2.70 -> C$2.90	N/A	View details for Rodman & Renshaw rating of GoGold Resources (TSE:GGD) on 12/21/2015
MVIS MicroVision	$1.42 -0.7%	12/17/2015	Initiated by	Rodman & Renshaw	-	Buy	$3.50	N/A	View details for Rodman & Renshaw rating of MicroVision (NASDAQ:MVIS) on 12/17/2015
CRMD CorMedix	$5.19 -2.6%	12/16/2015	Initiated by	Rodman & Renshaw	-	Buy		N/A	View details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 12/16/2015
VUZI Vuzix	$1.34	12/10/2015	Initiated by	Rodman & Renshaw	-	Buy	$10.00	N/A	View details for Rodman & Renshaw rating of Vuzix (NASDAQ:VUZI) on 12/10/2015
SRNE Sorrento Therapeutics	$0.02	12/7/2015	Reiterated by	Rodman & Renshaw	-	Buy	$45.00	N/A	View details for Rodman & Renshaw rating of Sorrento Therapeutics (NASDAQ:SRNE) on 12/7/2015
CRMD CorMedix	$5.19 -2.6%	11/12/2015	Initiated by	Rodman & Renshaw	-	Buy	$32.50	N/A	View details for Rodman & Renshaw rating of CorMedix (NASDAQ:CRMD) on 11/12/2015
BLDP Ballard Power Systems	$2.47 -2.8%	10/5/2015	Reiterated by	Rodman & Renshaw	-	Buy		N/A	View details for Rodman & Renshaw rating of Ballard Power Systems (NASDAQ:BLDP) on 10/5/2015
ORMP Oramed Pharmaceuticals	$2.30 -3.0%	10/1/2015	Initiated by	Rodman & Renshaw	-	Buy	$24.00	N/A	View details for Rodman & Renshaw rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 10/1/2015
BLDP Ballard Power Systems	$2.47 -2.8%	8/20/2015	Initiated by	Rodman & Renshaw	-	Buy	$2.50	N/A	View details for Rodman & Renshaw rating of Ballard Power Systems (NASDAQ:BLDP) on 8/20/2015
GEVO Gevo	$0.60 -10.5%	8/19/2015	Initiated by	Rodman & Renshaw	-	Buy	$100.00	N/A	View details for Rodman & Renshaw rating of Gevo (NASDAQ:GEVO) on 8/19/2015
BLDP Ballard Power Systems	$2.47 -2.8%	7/14/2015	Initiated by	Rodman & Renshaw	-	Buy		N/A	View details for Rodman & Renshaw rating of Ballard Power Systems (NASDAQ:BLDP) on 7/14/2015
CPRX Catalyst Pharmaceuticals	$14.68 -2.9%	8/27/2012	Upgraded by	Rodman & Renshaw	-	Market Perform -> Outperform	$3.70	N/A	View details for Rodman & Renshaw rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 8/27/2012
CYTK Cytokinetics	$64.80 -3.0%	7/31/2012	Reiterated by	Rodman & Renshaw	-	Outperform	$2.00	N/A	View details for Rodman & Renshaw rating of Cytokinetics (NASDAQ:CYTK) on 7/31/2012
ALNY Alnylam Pharmaceuticals	$143.71 -0.1%	7/31/2012	Reiterated by	Rodman & Renshaw	-	Outperform	$22.00	N/A	View details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 7/31/2012
BMY Bristol-Myers Squibb	$44.68 -8.6%	7/27/2012	Target Raised by	Rodman & Renshaw	-	Outperform	$38.00 -> $39.50	N/A	View details for Rodman & Renshaw rating of Bristol-Myers Squibb (NYSE:BMY) on 7/27/2012
AMGN Amgen	$269.38 -1.3%	7/23/2012	Target Raised by	Rodman & Renshaw	-	Outperform	$73.00 -> $89.00	N/A	View details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 7/23/2012
ALNY Alnylam Pharmaceuticals	$143.71 -0.1%	7/16/2012	Reiterated by	Rodman & Renshaw	-	Outperform		N/A	View details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 7/16/2012
ALGT Allegiant Travel	$57.99 -1.8%	7/13/2012	Target Raised by	Rodman & Renshaw	-	Outperform	$72.00 -> $79.00	N/A	View details for Rodman & Renshaw rating of Allegiant Travel (NASDAQ:ALGT) on 7/13/2012
BMY Bristol-Myers Squibb	$44.68 -8.6%	7/5/2012	Reiterated by	Rodman & Renshaw	-	Market Perform	$38.00	N/A	View details for Rodman & Renshaw rating of Bristol-Myers Squibb (NYSE:BMY) on 7/5/2012
ASMB Assembly Biosciences	$13.36 -0.9%	6/26/2012	Target Lowered by	Rodman & Renshaw	-		$132.00	N/A	View details for Rodman & Renshaw rating of Assembly Biosciences (NASDAQ:ASMB) on 6/26/2012
RPMT Rego Payment Architectures	$1.17 +12.5%	6/25/2012	Initiated by	Rodman & Renshaw	-	Outperform	$5.00	N/A	View details for Rodman & Renshaw rating of Rego Payment Architectures (OTCMKTS:RPMT) on 6/25/2012
AMGN Amgen	$269.38 -1.3%	6/21/2012	Target Raised by	Rodman & Renshaw	-	Outperform	$57.00 -> $73.00	N/A	View details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 6/21/2012
MNOV MediciNova	$1.32 -2.2%	6/19/2012	Reiterated by	Rodman & Renshaw	-	Outperform		N/A	View details for Rodman & Renshaw rating of MediciNova (NASDAQ:MNOV) on 6/19/2012
DCO Ducommun	$54.05	5/24/2012	Initiated by	Rodman & Renshaw	-	Market Perform		N/A	View details for Rodman & Renshaw rating of Ducommun (NYSE:DCO) on 5/24/2012
POWL Powell Industries	$146.31 -2.0%	5/10/2012	Upgraded by	Rodman & Renshaw	-	Market Perform -> Outperform	$43.00	N/A	View details for Rodman & Renshaw rating of Powell Industries (NASDAQ:POWL) on 5/10/2012
NPO Enpro	$149.78 -0.8%	5/4/2012	Target Raised by	Rodman & Renshaw	-	Outperform	$47.00 -> $50.00	N/A	View details for Rodman & Renshaw rating of Enpro (NYSE:NPO) on 5/4/2012
RMTI Rockwell Medical	$1.51 +1.3%	4/24/2012	Initiated by	Rodman & Renshaw	-	Outperform	$176.00	N/A	View details for Rodman & Renshaw rating of Rockwell Medical (NASDAQ:RMTI) on 4/24/2012
SYK Stryker	$337.09 +0.1%	4/20/2012	Downgraded by	Rodman & Renshaw	-	Outperform -> Market Perform		N/A	View details for Rodman & Renshaw rating of Stryker (NYSE:SYK) on 4/20/2012
PODD Insulet	$164.17 -1.8%	4/18/2012	Upgraded by	Rodman & Renshaw	-	Market Perform -> Outperform		N/A	View details for Rodman & Renshaw rating of Insulet (NASDAQ:PODD) on 4/18/2012
B Barnes Group	$35.89 -1.0%	4/3/2012	Initiated by	Rodman & Renshaw	-	Outperform		N/A	View details for Rodman & Renshaw rating of Barnes Group (NYSE:B) on 4/3/2012
TRS TriMas	$25.93 -1.3%	3/15/2012	Initiated by	Rodman & Renshaw	-	Outperform	$32.00	N/A	View details for Rodman & Renshaw rating of TriMas (NASDAQ:TRS) on 3/15/2012
OMER Omeros	$3.06 +0.7%	3/13/2012	Target Raised by	Rodman & Renshaw	-	Outperform	$13.00 -> $16.00	N/A	View details for Rodman & Renshaw rating of Omeros (NASDAQ:OMER) on 3/13/2012
AMGN Amgen	$269.38 -1.3%	3/7/2012	Reiterated by	Rodman & Renshaw	-	Outperform	$57.00	N/A	View details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 3/7/2012
VSTM Verastem	$9.22 -1.1%	3/7/2012	Initiated by	Rodman & Renshaw	-	Buy -> Market Perform		N/A	View details for Rodman & Renshaw rating of Verastem (NASDAQ:VSTM) on 3/7/2012
ANIP ANI Pharmaceuticals	$64.95 -0.7%	2/27/2012	Reiterated by	Rodman & Renshaw	-	Market Perform		N/A	View details for Rodman & Renshaw rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 2/27/2012
MNTX Manitex International	$5.55 -0.7%	2/23/2012	Target Raised by	Rodman & Renshaw	-		$10.00	N/A	View details for Rodman & Renshaw rating of Manitex International (NASDAQ:MNTX) on 2/23/2012
MDGL Madrigal Pharmaceuticals	$194.38 -5.0%	2/22/2012	Reiterated by	Rodman & Renshaw	-	Market Perform	$8.00	N/A	View details for Rodman & Renshaw rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 2/22/2012
MGIC Magic Software Enterprises	$11.58 -0.3%	2/15/2012	Target Raised by	Rodman & Renshaw	-	Outperform	$8.00 -> $10.00	N/A	View details for Rodman & Renshaw rating of Magic Software Enterprises (NASDAQ:MGIC) on 2/15/2012
ALNY Alnylam Pharmaceuticals	$143.71 -0.1%	2/6/2012	Target Raised by	Rodman & Renshaw	-	Outperform	$19.00	N/A	View details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/6/2012
DAL Delta Air Lines	$49.90 +4.1%	2/6/2012	Reiterated by	Rodman & Renshaw	-	Outperform	$14.00	N/A	View details for Rodman & Renshaw rating of Delta Air Lines (NYSE:DAL) on 2/6/2012
ALGT Allegiant Travel	$57.99 -1.8%	2/2/2012	Target Raised by	Rodman & Renshaw	-		$62.00	N/A	View details for Rodman & Renshaw rating of Allegiant Travel (NASDAQ:ALGT) on 2/2/2012
POWL Powell Industries	$146.31 -2.0%	1/26/2012	Initiated by	Rodman & Renshaw	-	Market Perform		N/A	View details for Rodman & Renshaw rating of Powell Industries (NASDAQ:POWL) on 1/26/2012
SILC Silicom	$15.38 -0.8%	1/24/2012	Target Raised by	Rodman & Renshaw	-	Outperform	$20.00 -> $25.00	N/A	View details for Rodman & Renshaw rating of Silicom (NASDAQ:SILC) on 1/24/2012
BMY Bristol-Myers Squibb	$44.68 -8.6%	1/23/2012	Reiterated by	Rodman & Renshaw	-	Outperform	$51.00	N/A	View details for Rodman & Renshaw rating of Bristol-Myers Squibb (NYSE:BMY) on 1/23/2012
LUV Southwest Airlines	$27.26 -7.0%	1/20/2012	Reiterated by	Rodman & Renshaw	-	Outperform	$12.00	N/A	View details for Rodman & Renshaw rating of Southwest Airlines (NYSE:LUV) on 1/20/2012
AMGN Amgen	$269.38 -1.3%	1/17/2012	Reiterated by	Rodman & Renshaw	-	Outperform	$57.00	N/A	View details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 1/17/2012
COOL Corner Growth Acquisition	$11.34 -2.8%	1/5/2012	Initiated by	Rodman & Renshaw	-	Outperform	$7.00	N/A	View details for Rodman & Renshaw rating of Corner Growth Acquisition (NASDAQ:COOL) on 1/5/2012
MDGL Madrigal Pharmaceuticals	$194.38 -5.0%	1/5/2012	Initiated by	Rodman & Renshaw	-	Outperform	$8.00	N/A	View details for Rodman & Renshaw rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 1/5/2012
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>>
ALNY Alnylam Pharmaceuticals	$143.71 -0.1%	1/4/2012	Reiterated by	Rodman & Renshaw	-	Outperform	$12.00	N/A	View details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 1/4/2012
WWD Woodward	$149.74 +0.1%	1/4/2012	Initiated by	Rodman & Renshaw	-	Outperform	$52.00	N/A	View details for Rodman & Renshaw rating of Woodward (NASDAQ:WWD) on 1/4/2012
AMGN Amgen	$269.38 -1.3%	12/23/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$57.00	N/A	View details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 12/23/2011
ANIP ANI Pharmaceuticals	$64.95 -0.7%	12/15/2011	Downgraded by	Rodman & Renshaw	-	Outperform -> Market Perform		N/A	View details for Rodman & Renshaw rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 12/15/2011
INTC Intel	$35.11 +1.8%	12/13/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$27.00	N/A	View details for Rodman & Renshaw rating of Intel (NASDAQ:INTC) on 12/13/2011
BMY Bristol-Myers Squibb	$44.68 -8.6%	12/13/2011	Target Lowered by	Rodman & Renshaw	-		$51.00	N/A	View details for Rodman & Renshaw rating of Bristol-Myers Squibb (NYSE:BMY) on 12/13/2011
ALNY Alnylam Pharmaceuticals	$143.71 -0.1%	12/12/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$12.00	N/A	View details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 12/12/2011
BMY Bristol-Myers Squibb	$44.68 -8.6%	12/12/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$52.50	N/A	View details for Rodman & Renshaw rating of Bristol-Myers Squibb (NYSE:BMY) on 12/12/2011
OMER Omeros	$3.06 +0.7%	12/5/2011	Upgraded by	Rodman & Renshaw	-	Market Perform -> Outperform	$13.00	N/A	View details for Rodman & Renshaw rating of Omeros (NASDAQ:OMER) on 12/5/2011
ROG Rogers	$109.54 +0.4%	12/2/2011	Initiated by	Rodman & Renshaw	-	Outperform	$55.00	N/A	View details for Rodman & Renshaw rating of Rogers (NYSE:ROG) on 12/2/2011
ALNY Alnylam Pharmaceuticals	$143.71 -0.1%	12/1/2011	Reiterated by	Rodman & Renshaw	-	Outperform		N/A	View details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 12/1/2011
AMGN Amgen	$269.38 -1.3%	12/1/2011	Initiated by	Rodman & Renshaw	-	Outperform	$62.00	N/A	View details for Rodman & Renshaw rating of Amgen (NASDAQ:AMGN) on 12/1/2011
CRIS Curis	$14.52 -1.7%	11/30/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$600.00	N/A	View details for Rodman & Renshaw rating of Curis (NASDAQ:CRIS) on 11/30/2011
EW Edwards Lifesciences	$88.01 -0.7%	11/29/2011	Reiterated by	Rodman & Renshaw	-	Market Perform		N/A	View details for Rodman & Renshaw rating of Edwards Lifesciences (NYSE:EW) on 11/29/2011
AAPL Apple	$169.89 +0.5%	11/29/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$16.07	N/A	View details for Rodman & Renshaw rating of Apple (NASDAQ:AAPL) on 11/29/2011
LUV Southwest Airlines	$27.26 -7.0%	11/21/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$12.00	N/A	View details for Rodman & Renshaw rating of Southwest Airlines (NYSE:LUV) on 11/21/2011
DELL Dell Technologies	$124.88 +3.9%	11/15/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$18.00	N/A	View details for Rodman & Renshaw rating of Dell Technologies (NYSE:DELL) on 11/15/2011
MNTX Manitex International	$5.55 -0.7%	11/15/2011	Initiated by	Rodman & Renshaw	-	Outperform	$6.50	N/A	View details for Rodman & Renshaw rating of Manitex International (NASDAQ:MNTX) on 11/15/2011
ALIM Alimera Sciences	$3.31 -8.8%	11/14/2011	Downgraded by	Rodman & Renshaw	-	Outperform -> Market Perform		N/A	View details for Rodman & Renshaw rating of Alimera Sciences (NASDAQ:ALIM) on 11/14/2011
EW Edwards Lifesciences	$88.01 -0.7%	11/11/2011	Reiterated by	Rodman & Renshaw	-	Market Perform		N/A	View details for Rodman & Renshaw rating of Edwards Lifesciences (NYSE:EW) on 11/11/2011
ADNT Adient	$29.41 -0.9%	11/11/2011	Initiated by	Rodman & Renshaw	-	Market Perform		N/A	View details for Rodman & Renshaw rating of Adient (NYSE:ADNT) on 11/11/2011
ALNY Alnylam Pharmaceuticals	$143.71 -0.1%	11/10/2011	Reiterated by	Rodman & Renshaw	-	Outperform		N/A	View details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 11/10/2011
INTC Intel	$35.11 +1.8%	11/10/2011	Reiterated by	Rodman & Renshaw	-	Outperform		N/A	View details for Rodman & Renshaw rating of Intel (NASDAQ:INTC) on 11/10/2011
CRIS Curis	$14.52 -1.7%	11/10/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$600.00	N/A	View details for Rodman & Renshaw rating of Curis (NASDAQ:CRIS) on 11/10/2011
AAPL Apple	$169.89 +0.5%	11/9/2011	Reiterated by	Rodman & Renshaw	-	Outperform		N/A	View details for Rodman & Renshaw rating of Apple (NASDAQ:AAPL) on 11/9/2011
GERN Geron	$3.56 -0.6%	11/9/2011	Target Lowered by	Rodman & Renshaw	-		$4.00	N/A	View details for Rodman & Renshaw rating of Geron (NASDAQ:GERN) on 11/9/2011
BMY Bristol-Myers Squibb	$44.68 -8.6%	11/9/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$52.50	N/A	View details for Rodman & Renshaw rating of Bristol-Myers Squibb (NYSE:BMY) on 11/9/2011
USEG U.S. Energy	$1.18 -2.5%	11/8/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$47.50	N/A	View details for Rodman & Renshaw rating of U.S. Energy (NASDAQ:USEG) on 11/8/2011
ERII Energy Recovery	$14.19 +1.5%	11/4/2011	Reiterated by	Rodman & Renshaw	-	Market Perform		N/A	View details for Rodman & Renshaw rating of Energy Recovery (NASDAQ:ERII) on 11/4/2011
AUDC AudioCodes	$10.43 -0.2%	11/1/2011	Reiterated by	Rodman & Renshaw	-	Outperform		N/A	View details for Rodman & Renshaw rating of AudioCodes (NASDAQ:AUDC) on 11/1/2011
CYTK Cytokinetics	$64.80 -3.0%	11/1/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$4.00	N/A	View details for Rodman & Renshaw rating of Cytokinetics (NASDAQ:CYTK) on 11/1/2011
ALNY Alnylam Pharmaceuticals	$143.71 -0.1%	11/1/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$12.00	N/A	View details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 11/1/2011
BMY Bristol-Myers Squibb	$44.68 -8.6%	10/28/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$52.50	N/A	View details for Rodman & Renshaw rating of Bristol-Myers Squibb (NYSE:BMY) on 10/28/2011
CEVA CEVA	$19.76 +0.4%	10/27/2011	Reiterated by	Rodman & Renshaw	-	Outperform		N/A	View details for Rodman & Renshaw rating of CEVA (NASDAQ:CEVA) on 10/27/2011
ALGT Allegiant Travel	$57.99 -1.8%	10/27/2011	Reiterated by	Rodman & Renshaw	-	Outperform		N/A	View details for Rodman & Renshaw rating of Allegiant Travel (NASDAQ:ALGT) on 10/27/2011
JBLU JetBlue Airways	$5.72 -3.2%	10/27/2011	Reiterated by	Rodman & Renshaw	-	Market Perform	$6.00	N/A	View details for Rodman & Renshaw rating of JetBlue Airways (NASDAQ:JBLU) on 10/27/2011
DAL Delta Air Lines	$49.90 +4.1%	10/26/2011	Target Raised by	Rodman & Renshaw	-		$14.00	N/A	View details for Rodman & Renshaw rating of Delta Air Lines (NYSE:DAL) on 10/26/2011
LUV Southwest Airlines	$27.26 -7.0%	10/21/2011	Reiterated by	Rodman & Renshaw	-	Outperform		N/A	View details for Rodman & Renshaw rating of Southwest Airlines (NYSE:LUV) on 10/21/2011
ALK Alaska Air Group	$44.55 +0.7%	10/21/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$39.00	N/A	View details for Rodman & Renshaw rating of Alaska Air Group (NYSE:ALK) on 10/21/2011
INTC Intel	$35.11 +1.8%	10/19/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$27.00	N/A	View details for Rodman & Renshaw rating of Intel (NASDAQ:INTC) on 10/19/2011
AAPL Apple	$169.89 +0.5%	10/19/2011	Reiterated by	Rodman & Renshaw	-	Outperform		N/A	View details for Rodman & Renshaw rating of Apple (NASDAQ:AAPL) on 10/19/2011
ENZ Enzo Biochem	$1.08 +1.9%	10/18/2011	Target Lowered by	Rodman & Renshaw	-	Outperform	$7.00 -> $5.00	N/A	View details for Rodman & Renshaw rating of Enzo Biochem (NYSE:ENZ) on 10/18/2011
ALNY Alnylam Pharmaceuticals	$143.71 -0.1%	10/14/2011	Initiated by	Rodman & Renshaw	-	Outperform	$12.00	N/A	View details for Rodman & Renshaw rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 10/14/2011
BMY Bristol-Myers Squibb	$44.68 -8.6%	10/14/2011	Initiated by	Rodman & Renshaw	-	Outperform	$52.50	N/A	View details for Rodman & Renshaw rating of Bristol-Myers Squibb (NYSE:BMY) on 10/14/2011
NPO Enpro	$149.78 -0.8%	10/13/2011	Initiated by	Rodman & Renshaw	-	Outperform	$47.00	N/A	View details for Rodman & Renshaw rating of Enpro (NYSE:NPO) on 10/13/2011
CYTK Cytokinetics	$64.80 -3.0%	10/13/2011	Initiated by	Rodman & Renshaw	-	Outperform	$4.00	N/A	View details for Rodman & Renshaw rating of Cytokinetics (NASDAQ:CYTK) on 10/13/2011
CEVA CEVA	$19.76 +0.4%	10/7/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$36.00	N/A	View details for Rodman & Renshaw rating of CEVA (NASDAQ:CEVA) on 10/7/2011
AAPL Apple	$169.89 +0.5%	10/5/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$16.07	N/A	View details for Rodman & Renshaw rating of Apple (NASDAQ:AAPL) on 10/5/2011
INTC Intel	$35.11 +1.8%	10/3/2011	Reiterated by	Rodman & Renshaw	-	Outperform		N/A	View details for Rodman & Renshaw rating of Intel (NASDAQ:INTC) on 10/3/2011
AGEN Agenus	$8.30 +11.9%	9/26/2011	Reiterated by	Rodman & Renshaw	-	Outperform	$40.00	N/A	View details for Rodman & Renshaw rating of Agenus (NASDAQ:AGEN) on 9/26/2011
CGA China Green Agriculture	$3.00	9/15/2011	Reiterated by	Rodman & Renshaw	-	Market Perform		N/A	View details for Rodman & Renshaw rating of China Green Agriculture (NYSE:CGA) on 9/15/2011
SEED Origin Agritech	$3.28 -7.3%	9/15/2011	Downgraded by	Rodman & Renshaw	-	Outperform -> Market Perform		N/A	View details for Rodman & Renshaw rating of Origin Agritech (NASDAQ:SEED) on 9/15/2011
SILC Silicom	$15.38 -0.8%	9/8/2011	Initiated by	Rodman & Renshaw	-	Outperform	$20.00	N/A	View details for Rodman & Renshaw rating of Silicom (NASDAQ:SILC) on 9/8/2011
URG Ur-Energy	$1.63 +1.2%	9/6/2011	Initiated by	Rodman & Renshaw	-	Outperform		N/A	View details for Rodman & Renshaw rating of Ur-Energy (NYSEAMERICAN:URG) on 9/6/2011
SYK Stryker	$337.09 +0.1%	8/15/2011	Upgraded by	Rodman & Renshaw	-	Market Perform -> Outperform	$56.00	N/A	View details for Rodman & Renshaw rating of Stryker (NYSE:SYK) on 8/15/2011
EW Edwards Lifesciences	$88.01 -0.7%	8/15/2011	Upgraded by	Rodman & Renshaw	-	Underperform -> Market Perform	$11.00	N/A	View details for Rodman & Renshaw rating of Edwards Lifesciences (NYSE:EW) on 8/15/2011
EXAS Exact Sciences	$58.79 -7.0%	8/15/2011	Upgraded by	Rodman & Renshaw	-	Market Perform -> Outperform	$7.00 -> $12.00	N/A	View details for Rodman & Renshaw rating of Exact Sciences (NASDAQ:EXAS) on 8/15/2011
URG Ur-Energy	$1.63 +1.2%	8/10/2011	Initiated by	Rodman & Renshaw	-	Outperform	$2.52	N/A	View details for Rodman & Renshaw rating of Ur-Energy (NYSEAMERICAN:URG) on 8/10/2011
EXAS Exact Sciences	$58.79 -7.0%	8/3/2011	Downgraded by	Rodman & Renshaw	-	Outperform -> Market Perform		N/A	View details for Rodman & Renshaw rating of Exact Sciences (NASDAQ:EXAS) on 8/3/2011
WOLF Wolfspeed	$24.87 +1.6%	8/2/2011	Upgraded by	Rodman & Renshaw	-	Market Perform -> Outperform	$5.00	N/A	View details for Rodman & Renshaw rating of Wolfspeed (NYSE:WOLF) on 8/2/2011

MarketBeat Community Rating for Rodman & Renshaw

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		24,215 (Vote Outperform)
Underperform Votes:		20,936 (Vote Underperform)
Total Votes:		45,151

MarketBeat's community ratings are surveys of what our community members think about Rodman & Renshaw and other research firms. Vote "Outperform" if you believe Rodman & Renshaw's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Rodman & Renshaw's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Rodman & Renshaw Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Rodman & Renshaw

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info